| Title： | Expert consensus on the diagnosis and treatment of Acanthamoeba keratitis |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | |
| Evidence classification method： | Level I evidence: evidence obtained from at least one well-designed randomized controlled clinical trial; Level II-1 evidence: evidence obtained from well-designed non-randomized controlled trials; Level II-2 evidence: evidence from well-designed cohort studies or case-control studies (preferably multi-center studies); Level II-3 evidence: evidence obtained from multiple time series studies with or without intervention. The results obtained in non-controlled trials with obvious differences can sometimes be used as evidence of this level; Level III evidence: authoritative opinions from clinical experience, descriptive research or expert committee reports. |
| Development unit： | Infection Group, Ophthalmology Credit Committee, Chinese Medical Association |
| Registration time: | 2023-01-30 |
| Registration number： | PREPARE-2023CN053 |
| Purpose of the guideline: |
Latest registration
